Thomas Tüting
#171,690
Most Influential Person Now
German dermatologist
Thomas Tüting's AcademicInfluence.com Rankings
Thomas Tütingphilosophy Degrees
Philosophy
#11149
World Rank
#15309
Historical Rank
Logic
#7950
World Rank
#9889
Historical Rank
Download Badge
Philosophy
Thomas Tüting's Degrees
- Doctorate Medicine University of Hamburg
Why Is Thomas Tüting Influential?
(Suggest an Edit or Addition)According to Wikipedia, Thomas Tüting is a German dermatologist and researcher at Otto von Guericke University Magdeburg. He is the clinical director of dermatology and the head of the Laboratory of Experimental Dermatology. His research interests include the identification and characterization of factors responsible for cancer progression and metastasis and resistance to cancer immunotherapy.
Thomas Tüting's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy (2014) (746)
- Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma (2014) (519)
- Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation (2012) (481)
- A comparison of two types of dendritic cell as adjuvants for the induction of melanoma‐specific T‐cell responses in humans following intranodal injection (2001) (396)
- 5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma (2008) (355)
- Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing. (2013) (311)
- Excitation-induced ataxin-3 aggregation in neurons from patients with Machado–Joseph disease (2011) (292)
- Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System (2007) (264)
- The experimental power of FR900359 to study Gq-regulated biological processes (2015) (251)
- Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma. (2001) (247)
- Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin (2018) (226)
- Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance? (2013) (226)
- Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation. (2014) (216)
- Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha. (1998) (209)
- Enhanced type I interferon signalling promotes Th1‐biased inflammation in cutaneous lupus erythematosus (2005) (208)
- Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive Patients (2006) (200)
- Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c‐MET Limit Cancer Immunotherapy (2017) (185)
- Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma (2017) (179)
- Systemic application of CpG‐rich DNA suppresses adaptive T cell immunity via induction of IDO (2006) (176)
- Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells. (2009) (169)
- Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope (2000) (168)
- Genome-wide in vivo screen identifies novel host regulators of metastatic colonization (2017) (166)
- An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis". (2008) (166)
- Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells (2009) (165)
- MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment (2015) (157)
- Genetically modified bone marrow‐derived dendritic cells expressing tumor‐associated viral or “self” antigens induce antitumor immunity in vivo (1997) (134)
- Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin‐homing cytotoxic lymphocytes associated with strong expression of the type I interferon‐induced protein MxA (2005) (123)
- Type I interferon‐associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis (2006) (118)
- Circulating clonal CLA+ and CD4+ T cells in Sézary syndrome express the skin‐homing chemokine receptors CCR4 and CCR10 as well as the lymph node‐homing chemokine receptor CCR7 (2005) (117)
- Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients (2005) (115)
- Protective role of palmitoylethanolamide in contact allergic dermatitis (2009) (113)
- Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9‐dependent maturation and IFN‐α production (2006) (112)
- DNA immunization targeting the skin: molecular control of adaptive immunity. (1998) (112)
- The expression pattern of interferon‐inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets (2007) (111)
- MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy. (2017) (111)
- Type I interferon‐associated cytotoxic inflammation in lichen planus (2006) (111)
- Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNλ) in cutaneous lupus erythematosus. (2011) (110)
- Genetic immunization of mice with human tyrosinase‐related protein 2: Implications for the immunotherapy of melanoma (2000) (104)
- Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesions. (2005) (104)
- Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. (2006) (99)
- Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3 (2008) (96)
- Interleukin-10-treated dendritic cells modulate immune responses of naive and sensitized T cells in vivo. (2002) (89)
- Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease. (2007) (87)
- Gene-based strategies for the immunotherapy of cancer (1997) (85)
- Induction of dendritic cell maturation and modulation of dendritic cell-induced immune responses by prostaglandins (2000) (84)
- Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice (1999) (79)
- Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12 (1999) (79)
- Identification of type I interferon‐associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches (2007) (78)
- Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients (2018) (74)
- Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression (2017) (72)
- Dendritic cell‐based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti‐melanoma immunity (1999) (69)
- How neutrophils promote metastasis (2016) (68)
- IFN-α-Expressing Tumor Cells Enhance Generation and Promote Survival of Tumor-Specific CTLs (2000) (68)
- RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas (2018) (67)
- Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2 (2006) (66)
- Absence of CD26 expression on skin‐homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome (2005) (65)
- Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity (2000) (64)
- Structural decoding of netrin-4 reveals a regulatory function towards mature basement membranes (2016) (63)
- Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus. (2005) (62)
- Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells. (2017) (62)
- Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice. (2006) (61)
- Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis. (2008) (61)
- Inflammasome-Dependent Induction of Adaptive NK Cell Memory. (2016) (61)
- Direct targeting of Gαq and Gα11 oncoproteins in cancer cells (2019) (60)
- Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus (2008) (60)
- Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin (2003) (59)
- Complete regression of advanced primary and metastatic mouse melanomas following combination chemoimmunotherapy. (2009) (59)
- Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4+ T cell-dependent mechanism (2001) (58)
- Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation? (2007) (57)
- Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma (2008) (56)
- Inflammation-Induced Plasticity in Melanoma Therapy and Metastasis. (2016) (55)
- Primary plasmacytoma of the skin. (1996) (55)
- Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation. (2006) (53)
- Peripheral CD8+ T cell tolerance against melanocytic self-antigens in the skin is regulated in two steps by CD4+ T cells and local inflammation: implications for the pathophysiology of vitiligo. (2005) (52)
- Anti‐inflammatory activity of topical THC in DNFB‐mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors (2013) (52)
- Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo. (2004) (50)
- Genetic immunization with a melanocytic self-antigen linked to foreign helper sequences breaks tolerance and induces autoimmunity and tumor immunity (2002) (50)
- Differential role of cannabinoids in the pathogenesis of skin cancer. (2015) (49)
- The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areata (2007) (48)
- Genome‐wide association study identifies new susceptibility loci for cutaneous lupus erythematosus (2015) (47)
- Pathogenesis of cutaneous lupus erythematosus: common and different features in distinct subsets (2010) (47)
- IFN-alpha-expressing tumor cells enhance generation and promote survival of tumor-specific CTLs. (2000) (46)
- Priming of T cells with Ad-transduced DC followed by expansion with peptide-pulsed DC significantly enhances the induction of tumor-specific CD8+ T cells: implications for an efficient vaccination strategy (2003) (46)
- Interferon-α gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models (1997) (46)
- Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen β-galactosidase and the BALB/c Meth A p53 tumor-specific antigen (1999) (46)
- Immunogenic cell death of human ovarian cancer cells induced by cytosolic poly(I:C) leads to myeloid cell maturation and activates NK cells (2011) (41)
- Potent antitumor immunity generated by a CD40-targeted adenoviral vaccine. (2011) (41)
- Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation (2013) (41)
- The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous cytotoxic T-cell lymphoma and pityriasis lichenoides. (2005) (41)
- Role of the Aryl Hydrocarbon Receptor in Environmentally Induced Skin Aging and Skin Carcinogenesis (2019) (41)
- A cell-permeable inhibitor to trap Gαq proteins in the empty pocket conformation. (2014) (41)
- RIG-I activation induces the release of extracellular vesicles with antitumor activity (2016) (40)
- IP10/CXCL10 - CXCR3 interaction: a potential self-recruiting mechanism for cytotoxic lymphocytes in lichen sclerosus et atrophicus. (2007) (38)
- Bioluminescence imaging allows measuring CD8 T cell function in the liver (2010) (38)
- Interferon‐α stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus (2011) (36)
- The expression of human leukocyte antigen‐DR and CD25 on circulating T cells in cutaneous lupus erythematosus and correlation with disease activity (2005) (36)
- Evidence for a role of type I interferons in the pathogenesis of dermatomyositis (2005) (35)
- A stochastic model for immunotherapy of cancer (2015) (35)
- CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus. (2007) (34)
- Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models (1999) (32)
- Autochthonous primary and metastatic melanomas in Hgf‐Cdk4R24C mice evade T‐cell‐mediated immune surveillance (2010) (32)
- Efficacy of low‐dose methotrexate in the treatment of dermatomyositis skin lesions (2012) (31)
- Neonatal UVB exposure accelerates melanoma growth and enhances distant metastases in Hgf‐Cdk4R24C C57BL/6 mice (2011) (30)
- The epidermal polarity protein Par3 is a non–cell autonomous suppressor of malignant melanoma (2017) (30)
- Transcriptional profiling identifies an interferon‐associated host immune response in invasive squamous cell carcinoma of the skin (2008) (30)
- CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease. (2008) (29)
- Successful rituximab treatment of severe pemphigus vulgaris resistant to multiple immunosuppressants. (2005) (28)
- Methotrexate treatment in cutaneous lupus erythematosus: subcutaneous application is as effective as intravenous administration (2006) (28)
- Treatment of recalcitrant dermatomyositis with efalizumab. (2006) (28)
- Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells (2016) (25)
- A Preclinical Model of Malignant Peripheral Nerve Sheath Tumor-like Melanoma Is Characterized by Infiltrating Mast Cells. (2016) (25)
- RIG-I Resists Hypoxia-Induced Immunosuppression and Dedifferentiation (2017) (25)
- Therapeutic Effectiveness of Recombinant Cancer Vaccines Is Associated with a Prevalent T-Cell Receptor α Usage by Melanoma-specific CD8+ T Lymphocytes (2004) (25)
- Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccine. (2011) (24)
- Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination (2005) (24)
- “Glowing Head” Mice: A Genetic Tool Enabling Reliable Preclinical Image-Based Evaluation of Cancers in Immunocompetent Allografts (2014) (24)
- Cannabinoid 1 receptors in keratinocytes attenuate fluorescein isothiocyanate‐induced mouse atopic‐like dermatitis (2014) (23)
- Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts (2020) (23)
- The Role of Neutrophilic Inflammation, Angiotropism, and Pericytic Mimicry in Melanoma Progression and Metastasis. (2016) (23)
- Enhanced CCR5+/CCR3+ T helper cell ratio in patients with active cutaneous lupus erythematosus (2011) (23)
- Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy (2002) (23)
- Enhanced skin expression of melanoma differentiation-associated gene 5 (MDA5) in dermatomyositis and related autoimmune diseases. (2011) (22)
- [Systemic treatment of cutaneous lupus erythematosus]. (2003) (21)
- Safety and Efficacy of Topically Applied Selected Cutibacterium acnes Strains over Five Weeks in Patients with Acne Vulgaris: An Open-label, Pilot Study. (2019) (21)
- Adoptive T Cell Therapy Targeting Different Gene Products Reveals Diverse and Context-Dependent Immune Evasion in Melanoma. (2020) (20)
- The immunology of cutaneous DNA immunization. (1999) (20)
- Evaluation of DNA vaccination with recombinant adenoviruses using bioluminescence imaging of antigen expression: impact of application routes and delivery with dendritic cells (2006) (19)
- Screening of Human Tumor Antigens for CD4+ T Cell Epitopes by Combination of HLA-Transgenic Mice, Recombinant Adenovirus and Antigen Peptide Libraries (2010) (18)
- Early Adenoviral Gene Expression Mediates Immunosuppression by Transduced Dendritic Cell (DC): Implications for Immunotherapy Using Genetically Modified DC1 (2004) (17)
- Successful treatment of recalcitrant malar rash in a patient with cutaneous lupus erythematosus with efalizumab (2008) (16)
- Autochthonous liver tumors induce systemic T cell tolerance associated with T cell receptor down‐modulation (2009) (16)
- Phorbol ester-induced neutrophilic inflammatory responses selectively promote metastatic spread of melanoma in a TLR4-dependent manner (2015) (15)
- Comparative evaluation of CD8+CTL responses following gene gun immunization targeting the skin with intracutaneous injection of antigen-transduced dendritic cells. (2007) (15)
- Restoration of Endogenous Retrovirus Infectivity Impacts Mouse Cancer Models (2018) (15)
- The immunology of DNA vaccines. (2000) (15)
- Impact of p53‐based immunization on primary chemically‐induced tumors (2005) (14)
- The aryl hydrocarbon receptor promotes inflammation‐induced dedifferentiation and systemic metastatic spread of melanoma cells (2020) (13)
- T cell immunotherapy for melanoma from bedside to bench to barn and back: how conceptual advances in experimental mouse models can be translated into clinical benefit for patients (2013) (13)
- Subacute cutaneous lupus erythematosus in a leuprorelin‐treated patient with prostate carcinoma (2008) (13)
- β-arrestin 2 inhibits proinflammatory chemokine production and attenuates contact allergic inflammation in the skin. (2014) (13)
- Toll-like receptor-agonists in the treatment of skin cancer: history, current developments and future prospects. (2008) (13)
- DNA vaccines targeting dendritic cells for the immunotherapy of cancer. (1998) (12)
- [Multiple skin cancers in a patient treated with hydroxyurea]. (2009) (12)
- Dickkopf-3 Contributes to the Regulation of Anti-Tumor Immune Responses by Mesenchymal Stem Cells (2015) (11)
- Proteasome-inhibited dendritic cells demonstrate improved presentation of exogenous synthetic and natural HLA-class I peptide epitopes. (2006) (11)
- Self-Antigen Presentation by Keratinocytes in the Inflamed Adult Skin Modulates T-Cell Auto-Reactivity. (2015) (11)
- Deletion of ADAM-9 in HGF/CDK4 mice impairs melanoma development and metastasis (2017) (10)
- Successful treatment of recalcitrant Wegener's granulomatosis of the skin with tacrolimus (PrografTM) (2004) (10)
- Evaluation of genetic melanoma vaccines in cdk4‐mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skin (2006) (10)
- Additional Her 2/neu gene copies in patients with Sézary syndrome. (2006) (10)
- Pancreatic panniculitis with polyarthritis (PPP syndrome) (2019) (9)
- Identification of a 17β-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide (2009) (9)
- IP 10 / CXCL 10 – CXCR 3 Interaction : a Potential Self-recruiting Mechanism for Cytotoxic Lymphocytes in Lichen Sclerosus et Atrophicus (9)
- Author Correction: Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin (2019) (8)
- Biolistic DNA vaccination against melanoma. (2013) (7)
- Interferon-alpha differentially affects homeostasis of human plasmacytoid and myeloid dendritic cells. (2009) (7)
- Cannabinoid Receptor 2 Modulates Maturation of Dendritic Cells and Their Capacity to Induce Hapten-Induced Contact Hypersensitivity (2020) (6)
- Neutrophils activated by membrane attack complexes increase the permeability of melanoma blood vessels (2022) (6)
- Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: A study of the German Central Malignant Melanoma Registry (2019) (5)
- XIAP promotes melanoma growth by inducing tumour neutrophil infiltration (2022) (5)
- Multicentre study on standardisation of melanoma cell culture – an initiative of the German Melanoma Research Network (2010) (5)
- Development of dendritic cell-based genetic vaccines for cancer. (1997) (5)
- Experimental and stochastic models of melanoma T-cell therapy define impact of subclone fitness on selection of antigen loss variants (2019) (5)
- Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin (2018) (5)
- Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment (2022) (4)
- Tumor cell intrinsic Toll‐like receptor 4 signaling promotes melanoma progression and metastatic dissemination (2021) (4)
- Regulatory Role of Cannabinoids for Skin Barrier Functions and Cutaneous Inflammation (2017) (4)
- Nitrosative stress: a hallmark of the junctional inflammation in cutaneous lupus erythematosus (2013) (4)
- Comprehensive Visualization of Longitudinal Patient Data for the Dermatological Oncological Tumor Board (2020) (3)
- Detection of a multilineage mosaic NRAS mutation c.181C>A (p.Gln61Lys) in an individual with a complex congenital nevus syndrome (2019) (3)
- CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological Checkpoints (2022) (3)
- Successful treatment of non‐uremic calciphylaxis with bisphosphonate (2020) (3)
- Overexpression of hepatocyte growth factor and an oncogenic CDK4 variant in mice alters corneal stroma morphology but does not lead to spontaneous ocular melanoma. (2016) (2)
- The myeloid cell type I IFN system promotes antitumor immunity over pro‐tumoral inflammation in cancer T‐cell therapy (2021) (2)
- E3 ubiquitin ligase HECTD2 mediates melanoma progression and immune evasion (2021) (2)
- Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG) (2020) (2)
- Activated Hgf-Met signaling cooperates with oncogenic Braf to drive primary cutaneous melanomas and angiotropic lung metastases in mice. (2020) (2)
- Live or Let Die: T Cell Survival in Cancer Immunotherapy. (2019) (2)
- [Topical treatment of bullous pemphigoid with tacrolimus. Case report with brief literature review]. (2005) (2)
- Morphologic and immunohistochemical features in the ageing Hgf-Cdk4 mouse eye (2014) (1)
- Successful Treatment of Bullous Congenital Ichthyosiform Erythroderma with Erythromycin (2007) (1)
- Melanoma Model Systems (2011) (1)
- Of swords and ploughshares: immunosurveillance and inflammation in melanoma (2010) (1)
- Abstract 5596: Intratumoral administration of a TLR9-adjuvanted nanoparticle cancer vaccine stimulates more effective immunity in both injected and un-injected tumor sites compared to subcutaneous administration (2017) (1)
- CRISPitope: A generic platform to model target antigens for adoptive T cell transfer therapy in mouse tumor models (2022) (1)
- Preoperative FDG-PET/CT imaging in the detection of regional lymph node metastases in stages I and II of malignant melanoma (2008) (1)
- [Cutaneous lesions in lupus erythematosus]. (2003) (1)
- N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy (2022) (1)
- Iconography : CXCR3 ligand–mediated skin inflammation in cutaneous lichenoid graft-versus-host disease (2013) (0)
- Abstract 3298: Propagation competence of a self-antigen-targeting arenavirus vector based cancer therapy determines antitumor efficacy in mouse melanoma (2022) (0)
- Persistent facial swelling (2022) (0)
- Author Correction: Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin (2019) (0)
- Multi-Objective Evolutionary Game Theory: A case study in cancer therapy (2022) (0)
- Reviewers' list (2005) (0)
- Systematic assessment of LCMV based vaccine vectors expressing melanocyte differentiation antigens in human in vitro assays and in mouse melanoma models. (2019) (0)
- [Immunological mechanisms of cognitive dysfunction under systemic therapy in metastatic melanoma]. (2022) (0)
- PS2-086 The efficacy of melanoma immunotherapy with cytosolically targeted immuno-stimulatory RNA requires a functional type I IFN system in the tumor microenvironment (2011) (0)
- Particle-Mediated Gene Transfer into Dendritic Cells : A Novel Strategy for the Induction of Immune Responses against Tumor Antigens. (2000) (0)
- Diagnostic performance of whole-body dual-modality 18F-FDG PET/CT imaging for N- and M-staging of 250 consecutive melanoma patients (2006) (0)
- Surveillance of patients with conjunctival melanoma in German-speaking countries: A multinational survey of the German dermatologic cooperative oncology group. (2020) (0)
- Altered intracellular sorting signals do not influence the efficacy of genetic melanoma vaccines incorporating helper determinants in mice (2005) (0)
- Cancer immunoediting by melanocyte differentiation antigen-specific T cells determines response to immune checkpoint inhibition (2021) (0)
- PS1-030. Tyrosine kinase inhibitor SU6668 blocks the polyIC-induced IFNλ-expression of keratinocytes: TBK1 as a potential drug-target for the treatment of cutaneous lupus erythematosus (2011) (0)
- Macrophage Stimulating 1 Receptor (2011) (0)
- RNA-Seq analysis of benign melanocytic nevi and primary melanomas (2017) (0)
- [Personalized medicine]. (2019) (0)
- Tumor cell intrinsic Tlr4 signaling promotes growth and metastasis in melanoma: P238 (o05/03) (2016) (0)
- Generation of the rGH-ffLuc-eGFP (“Glowing Head”) genetically engineered mouse. (2014) (0)
- [New directions in melanoma therapy]. (2008) (0)
- 1252 Interferon mediated resistance of melanoma cells to oncolytic viruses is regulated by the melanocyte lineage transcription factor MITF (2023) (0)
- Author index (2005) (0)
- Abstract 3514: A genetic-metabolic circuit of liver-specific metastatic organotropism (2023) (0)
- Acantholytic squamous cell carcinoma in a patient with junctional epidermolysis bullosa. (2023) (0)
- 289 Crosstalk between MET-dependent receptor tyrosine kinase signaling and oncogenic Gαq mutations in melanoma (2023) (0)
- A preclinical model of malignant peripheral nerve sheath tumor-like is characterized by infiltrating mast cells (2015) (0)
- 012 CD4+ T cells control immune evasive tumors by reprogramming myeloid cells in an IFN-dependent manner (2023) (0)
- 366 CD4+ T cells eradicate IFN-unresponsive melanomas that resist CD8+ T cell therapy (2023) (0)
- Reporter activity and metastasis of ffLuc-eGFP-labeled cancer cells are consistent in GH mice but suppressed in immunocompetent wildtype mice. (2014) (0)
- Adjuvant administration of plasmid DNA expressing IL-12 enhances the induction of anti-melanoma immune responses with plasmid DNA encoding the murine melanosomal protein TRP-2 (1998) (0)
- Abstract 981: A genetic-metabolic axis of metastatic liver organotropism (2022) (0)
This paper list is powered by the following services:
Other Resources About Thomas Tüting
What Schools Are Affiliated With Thomas Tüting?
Thomas Tüting is affiliated with the following schools:
